Zibo Revenue and Competitors
Estimated Revenue & Valuation
- Zibo's estimated annual revenue is currently $4.4M per year.
- Zibo's estimated revenue per employee is $120,000
Employee Data
- Zibo has 37 Employees.
Zibo's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO and Co-Founder | Reveal Email/Phone |
Zibo Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $98.6M | 526 | 2% | N/A | N/A |
#2 | $0.5M | 6 | -14% | N/A | N/A |
#3 | $16.2M | 108 | 1% | N/A | N/A |
#4 | $5M | 42 | -11% | N/A | N/A |
#5 | $4M | 33 | 3% | N/A | N/A |
#6 | $3M | 29 | -9% | N/A | N/A |
#7 | $3M | 29 | -6% | N/A | N/A |
#8 | $1.7M | 19 | -10% | N/A | N/A |
#9 | $112.6M | 591 | -13% | $174.9M | N/A |
#10 | $61.3M | 327 | 8% | N/A | N/A |
What Is Zibo?
Whether you own one rental unit or 100, Zibo provides access to world-class financial services designed for the unique needs of independent landlords. Landlords and property managers can manage everything from rent collection and bill payments, to banking, lending and insurance—all in one secure platform. Our simple, transparent tools help you save time, improve cash flow and grow your rental property portfolio.
keywords:N/A
N/A
Total Funding
37
Number of Employees
$4.4M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Zibo News
XZL Bio-Technology, Zibo Zichuan Chemical, Sanofi. This comprehensive Sodium Polystyrene Sulfonate Market report helps in determining the deficiencies and...
Hydroxyethyl Methacrylate Market Major Technology Giants in Buzz Again | Zibo Xinglu Chemical, Evonik, Anhui Renxin. A new business intelligence report...
Emerald Performance Materials, Zibo Qilong Chemical. This comprehensive CTBN Market report helps in determining the deficiencies and problems faced by...
Other Companies in Redwood City
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5M | 37 | N/A | N/A |
#2 | N/A | 37 | 12% | N/A |
#3 | $4.3M | 37 | N/A | N/A |
#4 | $4.1M | 37 | -3% | N/A |
#5 | $7.1M | 38 | 19% | $12M |